$CSR
Centerspace Stock $csr

$csr Overview Financials Valuation SEC Filings Company Website

2023 Q3 Form 10-Q Financial Statement

#000079835923000082 Filed on July 31, 2023

Income Statement

Concept	2023 Q3	2023 Q2
Revenue	$64.57M	$64.78M
YoY Change	-1.33%	2.63%
Cost Of Revenue	$2.197M	$27.29M
YoY Change	-14.28%	903.05%
Gross Profit	$62.37M	$37.48M
YoY Change	-0.8%	-37.94%
Gross Profit Margin	96.6%	57.87%
Selling, General & Admin	$3.832M	$4.162M
YoY Change	-15.2%	-20.28%
% of Gross Profit	6.14%	11.1%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$24.97M	$24.65M
YoY Change	4.13%	-1.53%
% of Gross Profit	40.03%	65.75%
Operating Expenses	$28.53M	$28.53M
YoY Change	1.03%	-4.86%
Operating Profit	$17.40M	$8.950M
YoY Change	147.4%	133.38%
Interest Expense	$8.556M	-$8.346M
YoY Change	8.7%	-210.38%
% of Operating Profit	49.19%	-93.25%
Other Income/Expense, Net
YoY Change
Pretax Income	$9.169M	-$2.380M
YoY Change	-1290.78%	-36.41%
Income Tax
% Of Pretax Income
Net Earnings	$7.774M	-$3.470M
YoY Change	-1586.42%	16.01%
Net Earnings / Revenue	12.04%	-5.36%
Basic Earnings Per Share	$0.41	-$0.23
Diluted Earnings Per Share	$0.41	-$0.23
COMMON SHARES
Basic Shares Outstanding	14.95M shares	14.96M shares
Diluted Shares Outstanding	18.02M shares	14.95M shares

Balance Sheet

Concept	2023 Q3	2023 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$29.70M	$9.745M
YoY Change	98.58%	-25.93%
Cash & Equivalents	$29.70M	$9.745M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets	$29.70M	$9.745M
YoY Change	98.58%	-25.93%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.810B	$1.891B
YoY Change	-9.62%	-1.19%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$22.50M	$566.0K
YoY Change	1487.58%	-70.43%
Total Long-Term Assets	$1.849B	$1.910B
YoY Change	-8.65%	-1.24%
TOTAL ASSETS
Total Short-Term Assets	$29.70M	$9.745M
Total Long-Term Assets	$1.849B	$1.910B
Total Assets	$1.878B	$1.920B
YoY Change	-7.86%	-1.41%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$62.67M	$56.71M
YoY Change	7.46%	17.96%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$62.67M	$56.71M
YoY Change	7.46%	17.96%
LONG-TERM LIABILITIES
Long-Term Debt	$838.7M	$881.5M
YoY Change	-13.31%	1.29%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$838.7M	$881.5M
YoY Change	-13.31%	1.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$62.67M	$56.71M
Total Long-Term Liabilities	$838.7M	$881.5M
Total Liabilities	$901.4M	$1.165B
YoY Change	-12.13%	26.87%
SHAREHOLDERS EQUITY
Retained Earnings	-$527.6M	-$522.8M
YoY Change	0.51%	2.2%
Common Stock	$1.169B	$1.170B
YoY Change	-3.36%	-3.17%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$733.5M	$755.0M
YoY Change
Total Liabilities & Shareholders Equity	$1.878B	$1.920B
YoY Change	-7.86%	-1.41%

Cashflow Statement

Concept	2023 Q3	2023 Q2
OPERATING ACTIVITIES
Net Income	$7.774M	-$3.470M
YoY Change	-1586.42%	16.01%
Depreciation, Depletion And Amortization	$24.97M	$24.65M
YoY Change	4.13%	-1.53%
Cash From Operating Activities	$31.86M	$23.76M
YoY Change	-7.61%	3.77%
INVESTING ACTIVITIES
Capital Expenditures	$14.33M	$13.84M
YoY Change	-112.48%	-232.11%
Acquisitions
YoY Change
Other Investing Activities	$82.46M	-$103.0K
YoY Change	6731.57%	-70.06%
Cash From Investing Activities	$68.13M	-$13.94M
YoY Change	-159.97%	28.86%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-58.10M	-57.35M
YoY Change	-172.25%	350.55%
NET CHANGE
Cash From Operating Activities	31.86M	23.76M
Cash From Investing Activities	68.13M	-13.94M
Cash From Financing Activities	-58.10M	-57.35M
Net Change In Cash	41.89M	-47.53M
YoY Change	3112.12%	7190.03%
FREE CASH FLOW
Cash From Operating Activities	$31.86M	$23.76M
Capital Expenditures	$14.33M	$13.84M
Free Cash Flow	$17.53M	$9.922M
YoY Change	-88.26%	-70.26%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q2	us-gaap	Temporary Equity Shares Issued TemporaryEquitySharesIssued	166000	shares
CY2022Q4	us-gaap	Temporary Equity Shares Outstanding TemporaryEquitySharesOutstanding	166000	shares
CY2023Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	14949000	shares
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14949000	shares
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	1273000	usd
	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	297000	usd
	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	6718000	usd
	us-gaap	Adjustments Related To Tax Withholding For Share Based Compensation AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation	179000	usd
	us-gaap	Stockholders Equity Other StockholdersEquityOther	140000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	965408000	usd
CY2022Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1025906000	usd
CY2022Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-3903000	usd
CY2022Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	188000	usd
CY2022Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.73
CY2022Q2	us-gaap	Dividends Common Stock DividendsCommonStock	11948000	usd
CY2022Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	480000	usd
CY2022Q2	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
CY2022Q2	csr	Partners Capital Account Cash Redemptions PartnersCapitalAccountCashRedemptions	327000	usd
CY2022Q2	us-gaap	Temporary Equity Issue Period Increase Or Decrease TemporaryEquityIssuePeriodIncreaseOrDecrease	3785000	usd
CY2022Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	198000	usd
CY2022Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	1010618000	usd
CY2023Q1	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	987805000	usd
CY2023Q2	us-gaap	Income Loss Including Portion Attributable To Noncontrolling Interest IncomeLossIncludingPortionAttributableToNoncontrollingInterest	-2540000	usd
CY2023Q2	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	159000	usd
CY2023Q2	us-gaap	Common Stock Dividends Per Share Declared CommonStockDividendsPerShareDeclared	0.73
CY2023Q2	us-gaap	Dividends Common Stock DividendsCommonStock	11608000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	590000	usd
CY2023Q2	us-gaap	Partners Capital Account Redemptions PartnersCapitalAccountRedemptions	0	usd
CY2023Q2	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	5696000	usd
CY2023Q2	us-gaap	Stockholders Equity Other StockholdersEquityOther	5000	usd
CY2023Q2	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	965408000	usd
	us-gaap	Profit Loss ProfitLoss	49947000	usd
	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	51295000	usd
	us-gaap	Gains Losses On Sales Of Investment Real Estate GainsLossesOnSalesOfInvestmentRealEstate	60159000	usd
	csr	Gain Loss Relatedto Litigation Settlement Non Cash Portion GainLossRelatedtoLitigationSettlementNonCashPortion	-2864000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	2109000	usd
	csr	Gain Loss On Interest Rate Swap Mark To Market And Settlement Amortization GainLossOnInterestRateSwapMarkToMarketAndSettlementAmortization	-297000	usd
	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-94000	usd
	us-gaap	Increase Decrease In Other Operating Assets IncreaseDecreaseInOtherOperatingAssets	-2866000	usd
	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	-3752000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	45561000	usd
	csr	Proceeds From Sale Of Real Estate And Other Investments ProceedsFromSaleOfRealEstateAndOtherInvestments	141587000	usd
	csr	Proceeds From Sale Of Real Estate And Other Investments ProceedsFromSaleOfRealEstateAndOtherInvestments	0	usd
	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	0	usd
	us-gaap	Payments To Acquire Residential Real Estate PaymentsToAcquireResidentialRealEstate	9546000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	25072000	usd
	us-gaap	Payments For Capital Improvements PaymentsForCapitalImprovements	13945000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	-731000	usd
	us-gaap	Payments For Proceeds From Other Investing Activities PaymentsForProceedsFromOtherInvestingActivities	56000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	117246000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-23547000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	90000000	usd
	us-gaap	Proceeds From Secured Notes Payable ProceedsFromSecuredNotesPayable	0	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	22796000	usd
	us-gaap	Repayments Of Notes Payable RepaymentsOfNotesPayable	25911000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	62279000	usd
	us-gaap	Proceeds From Lines Of Credit ProceedsFromLinesOfCredit	45000000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	156790000	usd
	us-gaap	Repayments Of Lines Of Credit RepaymentsOfLinesOfCredit	48000000	usd
	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	100000000	usd
	us-gaap	Repayments Of Unsecured Debt RepaymentsOfUnsecuredDebt	0	usd
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	usd
	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	3209000	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	usd
	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	31569000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	6718000	usd
	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	0	usd
	us-gaap	Payments For Repurchase Of Redeemable Noncontrolling Interest PaymentsForRepurchaseOfRedeemableNoncontrollingInterest	3205000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	21879000	usd
	us-gaap	Payments Of Dividends Common Stock PaymentsOfDividendsCommonStock	22030000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3214000	usd
	us-gaap	Payments Of Dividends Preferred Stock And Preference Stock PaymentsOfDividendsPreferredStockAndPreferenceStock	3214000	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders PaymentsOfOrdinaryDividendsPreferredUnitholders	320000	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders PaymentsOfOrdinaryDividendsPreferredUnitholders	320000	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	4809000	usd
	us-gaap	Payments Of Distributions To Affiliates PaymentsOfDistributionsToAffiliates	4842000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-140000	usd
	us-gaap	Proceeds From Payments For Other Financing Activities ProceedsFromPaymentsForOtherFinancingActivities	-337000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-164387000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-34499000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1580000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-23555000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11891000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38625000	usd
	csr	Adjustments To Accounts Payable Included Within Real Estate Investments AdjustmentsToAccountsPayableIncludedWithinRealEstateInvestments	4638000	usd
	csr	Adjustments To Accounts Payable Included Within Real Estate Investments AdjustmentsToAccountsPayableIncludedWithinRealEstateInvestments	2442000	usd
	csr	Conversion Of Stock Amount Converted Net ConversionOfStockAmountConvertedNet	-1021000	usd
	csr	Conversion Of Stock Amount Converted Net ConversionOfStockAmountConvertedNet	-375000	usd
CY2023Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11608000	usd
CY2022Q2	us-gaap	Dividends Payable Current And Noncurrent DividendsPayableCurrentAndNoncurrent	11948000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	2120000	usd
	us-gaap	Conversion Of Stock Amount Converted1 ConversionOfStockAmountConverted1	0	usd
	csr	Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes	179000	usd
	csr	Noncash Or Part Noncash Transaction Retirement Of Shares Withheld For Taxes NoncashOrPartNoncashTransactionRetirementOfSharesWithheldForTaxes	1273000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1060000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Debt Assumed1 NoncashOrPartNoncashAcquisitionDebtAssumed1	41623000	usd
	csr	Fair Value Adjustment Debt FairValueAdjustmentDebt	1224000	usd
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	0	usd
	us-gaap	Noncash Or Part Noncash Acquisition Investments Acquired1 NoncashOrPartNoncashAcquisitionInvestmentsAcquired1	43276000	usd
	csr	Noncash Or Part Noncash Acquisition Write Off Of Receivable In Exchange For Property NoncashOrPartNoncashAcquisitionWriteOffOfReceivableInExchangeForProperty	0	usd
	csr	Noncash Or Part Noncash Acquisition Write Off Of Receivable In Exchange For Property NoncashOrPartNoncashAcquisitionWriteOffOfReceivableInExchangeForProperty	43276000	usd
	us-gaap	Interest Paid Net InterestPaidNet	11867000	usd
	us-gaap	Interest Paid Net InterestPaidNet	14439000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9745000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10458000	usd
CY2022Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	13156000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	566000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1433000	usd
CY2022Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1914000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	10311000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	11891000	usd
CY2022Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	15070000	usd
	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">USE OF ESTIMATES</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates.</span></div>
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Remainder Of Fiscal Year LessorOperatingLeasePaymentsToBeReceivedRemainderOfFiscalYear	1599000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	3165000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	3122000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Three Years LessorOperatingLeasePaymentsToBeReceivedThreeYears	2524000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received Four Years LessorOperatingLeasePaymentsToBeReceivedFourYears	1444000	usd
CY2023Q2	csr	Lessor Operating Lease Payment To Be Received After Year Four LessorOperatingLeasePaymentToBeReceivedAfterYearFour	6243000	usd
CY2023Q2	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	18097000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	123932000	usd
	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	116061000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	6517000	usd
	us-gaap	Variable Lease Income VariableLeaseIncome	4822000	usd
CY2023Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1607000	usd
CY2022Q2	us-gaap	Dividends Preferred Stock DividendsPreferredStock	1607000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2224000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	2547000	usd
	us-gaap	Revenues Revenues	132673000	usd
	us-gaap	Revenues Revenues	123430000	usd
	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">MARKET CONCENTRATION RISK</span></div><div style="margin-bottom:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We are subject to increased exposure from economic and other competitive factors specific to markets where we hold a significant percentage of the carrying value of our real estate portfolio. As of June 30, 2023, we held more than 10% of the carrying value of our real estate portfolio in each of the following markets: Minneapolis, Minnesota and Denver, Colorado.</span></div>
CY2023Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2022Q2	us-gaap	Impairment Of Real Estate ImpairmentOfRealEstate	0	usd
CY2023Q2	us-gaap	Advertising Expense AdvertisingExpense	744000	usd
CY2022Q2	us-gaap	Advertising Expense AdvertisingExpense	894000	usd
	us-gaap	Advertising Expense AdvertisingExpense	1400000	usd
	us-gaap	Advertising Expense AdvertisingExpense	1600000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	1000000	usd
CY2023Q2	us-gaap	Estimated Insurance Recoveries EstimatedInsuranceRecoveries	1300000	usd
CY2023Q2	csr	Estimated Insurance Recoveries Remaining Amount EstimatedInsuranceRecoveriesRemainingAmount	300000	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2900000	usd
	csr	Ratio Of Units Exchanged For Shares RatioOfUnitsExchangedForShares	1
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1863000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-2991000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-3470000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4598000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	38494000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-14794000	usd
CY2023Q2	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	712000	usd
CY2022Q2	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	950000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	-7854000	usd
	us-gaap	Noncontrolling Interest In Net Income Loss Operating Partnerships Nonredeemable NoncontrollingInterestInNetIncomeLossOperatingPartnershipsNonredeemable	3107000	usd
CY2023Q2	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	160000	usd
CY2022Q2	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	160000	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	320000	usd
	csr	Payments Of Ordinary Dividends Preferred Unitholders Accrued Amount PaymentsOfOrdinaryDividendsPreferredUnitholdersAccruedAmount	320000	usd
CY2023Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-4022000	usd
CY2022Q2	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-5388000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	46668000	usd
	us-gaap	Net Income Loss Available To Common Stockholders Diluted NetIncomeLossAvailableToCommonStockholdersDiluted	-17581000	usd
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14949000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15369000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	14987000	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	15233000	shares
CY2023Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2022Q2	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	967000	shares
	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0	shares
CY2023Q2	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
CY2022Q2	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	20000	shares
	csr	Incremental Common Shares Attributable To Conversion Of Restricted Stock IncrementalCommonSharesAttributableToConversionOfRestrictedStock	0	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	14949000	shares
CY2022Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15369000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18313000	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	15233000	shares
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.23
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.30
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.57
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.97
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.23
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.30
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.55
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.97
CY2023Q2	csr	Noncontrolling Interests In Operating Partnership Units Outstanding NoncontrollingInterestsInOperatingPartnershipUnitsOutstanding	961000	shares
CY2022Q4	csr	Noncontrolling Interests In Operating Partnership Units Outstanding NoncontrollingInterestsInOperatingPartnershipUnitsOutstanding	971000	shares
	csr	Noncontrolling Interest In Operating Partnership Units Issued NoncontrollingInterestInOperatingPartnershipUnitsIssued	209000	shares
	csr	Number Of Real Estate Properties Acquired NumberOfRealEstatePropertiesAcquired	3	apartmentcommunity
CY2023Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	14900000	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	15000000	shares
	us-gaap	Sales Commissions And Fees SalesCommissionsAndFees	338000	usd
CY2022Q1	us-gaap	Stock Repurchase Program Authorized Amount1 StockRepurchaseProgramAuthorizedAmount1	50000000	usd
CY2023Q2	us-gaap	Stock Repurchase Program Remaining Authorized Repurchase Amount1 StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1	14200000	usd
CY2023Q2	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	105000	shares
CY2023Q2	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	5696000	usd
CY2023Q2	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	54.51
	us-gaap	Treasury Stock Shares Acquired TreasuryStockSharesAcquired	124000	shares
	us-gaap	Treasury Stock Value Acquired Cost Method TreasuryStockValueAcquiredCostMethod	6718000	usd
	us-gaap	Treasury Stock Acquired Average Cost Per Share TreasuryStockAcquiredAverageCostPerShare	54.19
CY2023Q2	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	885518000	usd
CY2023Q2	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0354
CY2022Q4	us-gaap	Debt Instrument Carrying Amount DebtInstrumentCarryingAmount	1011777000	usd
CY2022Q4	us-gaap	Debt Weighted Average Interest Rate DebtWeightedAverageInterestRate	0.0362
	csr	Debt Instrument Weighted Average Maturity DebtInstrumentWeightedAverageMaturity	P6Y11M4D
CY2023Q2	csr	Number Of Real Estate Properties Unencumbered NumberOfRealEstatePropertiesUnencumbered	49	apartmentcommunity
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	25340000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	7358000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	53277000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	51590000	usd
CY2023Q2	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	48666000	usd
CY2023Q2	csr	Long Term Debt Maturity After Year Four LongTermDebtMaturityAfterYearFour	699287000	usd
CY2023Q2	us-gaap	Long Term Debt LongTermDebt	885518000	usd
	us-gaap	Cash Flow Hedge Gain Loss To Be Reclassified Within Twelve Months CashFlowHedgeGainLossToBeReclassifiedWithinTwelveMonths	1000000	usd
CY2022Q2	csr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
CY2023Q2	csr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
	csr	Number Of Acquisitions During Period NumberOfAcquisitionsDuringPeriod	0	acquisition
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	116900000	usd
	us-gaap	Business Combination Consideration Transferred1 BusinessCombinationConsiderationTransferred1	116874000	usd
	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	9093000	usd
	us-gaap	Business Combination Consideration Transferred Equity Interests Issued And Issuable BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable	22882000	usd
	us-gaap	Business Combination Consideration Transferred Other1 BusinessCombinationConsiderationTransferredOther1	84899000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Land BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLand	7339000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Buildings BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedBuildings	106080000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill	4672000	usd
CY2022Q2	us-gaap	Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Financial Liabilities BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedFinancialLiabilities	1217000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	893000	usd
	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10600000	usd
CY2023Q2	csr	Number Of Exchange Transactions NumberOfExchangeTransactions	4	transaction
CY2023Q2	us-gaap	Interest Expense InterestExpense	8641000	usd
CY2022Q2	us-gaap	Interest Expense InterestExpense	7561000	usd
	us-gaap	Interest Expense InterestExpense	18960000	usd
	us-gaap	Revenues Revenues	123430000	usd
	csr	Property Operating Expense PropertyOperatingExpense	52089000	usd
	csr	Net Operating Income Loss NetOperatingIncomeLoss	71341000	usd
	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	4974000	usd
	csr	Insurance Gain Loss Casualty InsuranceGainLossCasualty	-980000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	55769000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	9721000	usd
	us-gaap	Gain Loss On Sale Of Investments GainLossOnSaleOfInvestments	27000	usd
	us-gaap	Interest Expense InterestExpense	15276000	usd
	csr	Interest And Other Income Loss InterestAndOtherIncomeLoss	1046000	usd
	us-gaap	Profit Loss ProfitLoss	-14306000	usd
CY2023Q2	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2434138000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	543264000	usd
CY2023Q2	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1890874000	usd
CY2023Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	9745000	usd
CY2023Q2	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	566000	usd
CY2023Q2	us-gaap	Other Assets OtherAssets	18992000	usd
CY2023Q2	us-gaap	Assets Assets	1920177000	usd
CY2022Q4	us-gaap	Real Estate Investment Property At Cost RealEstateInvestmentPropertyAtCost	2534124000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Accumulated Depreciation RealEstateInvestmentPropertyAccumulatedDepreciation	535401000	usd
CY2022Q4	us-gaap	Real Estate Investment Property Net RealEstateInvestmentPropertyNet	1998723000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10458000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1433000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	22687000	usd
CY2022Q4	us-gaap	Assets Assets	2033301000	usd
CY2023Q2	us-gaap	Gain Loss Related To Litigation Settlement GainLossRelatedToLitigationSettlement	-2900000	usd
CY2023Q2	csr	Number Of Real Estate Technology Venture Funds With Unfunded Commitments NumberOfRealEstateTechnologyVentureFundsWithUnfundedCommitments	2	realestatetechnologyventurefund
CY2015Q3	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized	775000	shares
CY2015Q3	csr	Share Based Compensation Arrangement By Share Based Payment Award Term Of Award ShareBasedCompensationArrangementByShareBasedPaymentAwardTermOfAward	P10Y
CY2023Q1	us-gaap	Share Price SharePrice	58.67
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	590000	usd
CY2022Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	480000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	2100000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	1200000	usd
CY2023Q2	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2023Q2	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2023Q2	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0000798359-23-000082-index-headers.html	Edgar Link	pending
0000798359-23-000082-index.html	Edgar Link	pending
0000798359-23-000082.txt	Edgar Link	pending
0000798359-23-000082-xbrl.zip	Edgar Link	pending
centerspace063023-10qex311.htm	Edgar Link	pending
centerspace063023-10qex312.htm	Edgar Link	pending
centerspace063023-10qex321.htm	Edgar Link	pending
centerspace063023-10qex322.htm	Edgar Link	pending
csr-20230630.htm	Edgar Link	pending
csr-20230630.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
csr-20230630_def.xml	Edgar Link	unprocessable
csr-20230630_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
csr-20230630_pre.xml	Edgar Link	unprocessable
csr-20230630_htm.xml	Edgar Link	completed
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
csr-20230630_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CSR
Centerspace Stock $csr

2023 Q3 Form 10-Q Financial Statement

#000079835923000082 Filed on July 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSR Centerspace Stock $csr

2023 Q3 Form 10-Q Financial Statement

#000079835923000082 Filed on July 31, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CSR
Centerspace Stock $csr